Literature DB >> 18782602

Synphilin-1 transgenic mice exhibit mild motor impairments.

Hong-Guo Jin1, Hiroshi Yamashita, Takeshi Nakamura, Hiromasa Fukuba, Tetsuya Takahashi, Masanori Hiji, Tatsuo Kohriyama, Masayasu Matsumoto.   

Abstract

Synphilin-1 represents a cytoplasmic protein that interacts with alpha-synuclein and localizes close to synaptic vesicles. The interaction of synphilin-1 with several proteins involved in Parkinson's disease suggests that it might be involved in the pathogenesis of the disease. Nonetheless, the function of synphilin-1 remains unclear. In the present study, we generated transgenic mice expressing human synphilin-1 under the prion protein promoter. Synphilin-1 was widely expressed in neurons in the brain including the substantia nigra, where massive loss of dopamine neurons was not observed. In the transgenic mouse brain, synphilin-1 protein was polyubiquitinated, and partially insoluble. Although modified-SHIRPA revealed no significant difference in behavior and morphology, the reduced rotarod performance and step length were observed in transgenic mice as compared with non-transgenic littermates. Synphilin-1 might be involved in motor function, and its accumulation in the central nervous system can cause motor impairments.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18782602     DOI: 10.1016/j.neulet.2008.08.073

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

Review 1.  Genetically engineered mouse models of Parkinson's disease.

Authors:  Donna M Crabtree; Jianhua Zhang
Journal:  Brain Res Bull       Date:  2011-08-03       Impact factor: 4.077

2.  Synphilin-1 attenuates neuronal degeneration in the A53T alpha-synuclein transgenic mouse model.

Authors:  Wanli W Smith; Zhaohui Liu; Yideng Liang; Naoki Masuda; Debbie A Swing; Nancy A Jenkins; Neal G Copeland; Juan C Troncoso; Mikhail Pletnikov; Ted M Dawson; Lee J Martin; Timothy H Moran; Michael K Lee; David R Borchelt; Christopher A Ross
Journal:  Hum Mol Genet       Date:  2010-02-25       Impact factor: 6.150

3.  Synphilin-1A is a phosphoprotein phosphatase 1-interacting protein and affects PPP1 sorting to subcellular compartments.

Authors:  Emanuel Ferreira-Fernandes; Sara L C Esteves; Luís Korrodi-Gregório; Georg Luers; Vera Afreixo; Margarida Fardilha; Odete A B da Cruz e Silva
Journal:  J Mol Neurosci       Date:  2014-06-06       Impact factor: 3.444

4.  Exploration of the Common Gene Characteristics and Molecular Mechanism of Parkinson's Disease and Crohn's Disease from Transcriptome Data.

Authors:  Haoran Zheng; Xiaohang Qian; Wotu Tian; Li Cao
Journal:  Brain Sci       Date:  2022-06-13

5.  Synphilin-1 enhances α-synuclein aggregation in yeast and contributes to cellular stress and cell death in a Sir2-dependent manner.

Authors:  Sabrina Büttner; Charlotte Delay; Vanessa Franssens; Tine Bammens; Doris Ruli; Sandra Zaunschirm; Rita Machado de Oliveira; Tiago Fleming Outeiro; Frank Madeo; Luc Buée; Marie-Christine Galas; Joris Winderickx
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

6.  Transgenic overexpression of the alpha-synuclein interacting protein synphilin-1 leads to behavioral and neuropathological alterations in mice.

Authors:  Silke Nuber; Thomas Franck; Hartwig Wolburg; Ulrike Schumann; Nicolas Casadei; Kristina Fischer; Carsten Calaminus; Bernd J Pichler; Sittinan Chanarat; Peter Teismann; Jörg B Schulz; Andreas R Luft; Jürgen Tomiuk; Johannes Wilbertz; Antje Bornemann; Rejko Krüger; Olaf Riess
Journal:  Neurogenetics       Date:  2010-02       Impact factor: 2.660

7.  The Protein Complex of Neurodegeneration-related Phosphoinositide Phosphatase Sac3 and ArPIKfyve Binds the Lewy Body-associated Synphilin-1, Preventing Its Aggregation.

Authors:  Ognian C Ikonomov; Diego Sbrissa; Lauren M Compton; Rita Kumar; Ellen J Tisdale; Xuequn Chen; Assia Shisheva
Journal:  J Biol Chem       Date:  2015-09-24       Impact factor: 5.157

8.  A novel obesity model: synphilin-1-induced hyperphagia and obesity in mice.

Authors:  X Li; K L K Tamashiro; Z Liu; N T Bello; X Wang; S Aja; S Bi; E E Ladenheim; C A Ross; T H Moran; W W Smith
Journal:  Int J Obes (Lond)       Date:  2011-12-13       Impact factor: 5.095

9.  Yeasts as Complementary Model Systems for the Study of the Pathological Repercussions of Enhanced Synphilin-1 Glycation and Oxidation.

Authors:  David Seynnaeve; Daniel P Mulvihill; Joris Winderickx; Vanessa Franssens
Journal:  Int J Mol Sci       Date:  2021-02-07       Impact factor: 5.923

10.  A LRRK2 GTP Binding Inhibitor, 68, Reduces LPS-Induced Signaling Events and TNF-α Release in Human Lymphoblasts.

Authors:  Tianxia Li; Bo Ning; Lingbo Kong; Bingling Dai; Xiaofei He; Joseph M Thomas; Akira Sawa; Christopher A Ross; Wanli W Smith
Journal:  Cells       Date:  2021-02-23       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.